CryoCath Technologies

CYT-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about CYT-T

Signal
Opinion
Expert
WAIT
WAIT
March 23, 2004
Good management. Have a better surgical procedure. People are starting to be convinced that it is better. Could be approaching the hockey stick growth curve. Wait for confirmation that revenues are accelerating.
Show full opinionHide full opinion
Good management. Have a better surgical procedure. People are starting to be convinced that it is better. Could be approaching the hockey stick growth curve. Wait for confirmation that revenues are accelerating.
WEAK BUY
WEAK BUY
February 20, 2004
In a transition area. Pretty good product. Think they've turned a corner and should have a good year.
Show full opinionHide full opinion
In a transition area. Pretty good product. Think they've turned a corner and should have a good year.
DON'T BUY
DON'T BUY
January 15, 2004
Have very good technology. Earnings improved from minus .96 cents to minus.41 cents. Stock ranks in the bottom 10% of the database.
Show full opinionHide full opinion
Have very good technology. Earnings improved from minus .96 cents to minus.41 cents. Stock ranks in the bottom 10% of the database.
PAST TOP PICK
PAST TOP PICK
October 24, 2003
(Top pick Aug 13/03. Down 25%.) Saw a very large shareholder sell which drove down the stock price. That has to be digested. Should see revenues ramping up and new product approvals happening. Good technology.
Show full opinionHide full opinion
(Top pick Aug 13/03. Down 25%.) Saw a very large shareholder sell which drove down the stock price. That has to be digested. Should see revenues ramping up and new product approvals happening. Good technology.
TOP PICK
TOP PICK
August 13, 2003
Focused on cardiovascular and intro fibrillation market.Should see sales ramp up this year.A very rapidly growing space.There is a potential for a take out.
Show full opinionHide full opinion
Focused on cardiovascular and intro fibrillation market.Should see sales ramp up this year.A very rapidly growing space.There is a potential for a take out.
DON'T BUY
DON'T BUY
July 10, 2003
A very good company. Starting to get massive approval. Would like to see better traction on revenues. Voatile.
Show full opinionHide full opinion
A very good company. Starting to get massive approval. Would like to see better traction on revenues. Voatile.
BUY
BUY
May 29, 2003
If you like biotechs, this could be OK. Speculative.
Show full opinionHide full opinion
If you like biotechs, this could be OK. Speculative.
DON'T BUY
DON'T BUY
March 27, 2003
A little bit suspect on the company at this time.
Show full opinionHide full opinion
A little bit suspect on the company at this time.
Showing 16 to 23 of 23 entries